🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Steven J. Isakoff

Harvard University

ORCID: 0000-0002-6677-1014

Also affiliated with Massachusetts General Hospital, Global Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer”.

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.02.008

N/A

0DataRank · unranked

157 citations

Ofir Cohen, Bose Kochupurakkal, D. Kim, Connor E. Dunn, Jorge Buendia +20 more

Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0638

N/A

0DataRank · unranked

24 citations

Taronish D. Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch +24 more

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0702

N/A

0DataRank · unranked

229 citations

Sheng Sun, Ignaty Leshchiner, Nayana Thimmiah, Elizabeth E. Martin, Daniel E. McLoughlin +17 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

0DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more

The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer

Journal of the National Comprehensive Cancer Network(2022)10.6004/jnccn.2022.7016

N/A

0DataRank · unranked

80 citations

Yael Bar, Steven J. Isakoff, Laura M. Spring

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

The Oncologist(2022)10.1093/oncolo/oyac134

N/A

0DataRank · unranked

22 citations

Rebecca S. Heist, Adam Z. Bard, Annacarolina F L da Silva, Ibiayi Dagogo‐Jack, Valentina Nardi +45 more

An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression

Frontiers in Oncology(2022)10.3389/fonc.2022.809715

N/A

0DataRank · unranked

3 citations

Read Allen, Lin Jia, Ting Sun, Steven J. Isakoff, Marielle Scherrer‐Crosbie +11 more

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0704

N/A

0DataRank · unranked

61 citations

Ferran Fece de la Cruz, Elizabeth E. Martin, Bryanna L. Norden, Nicholas Chevalier, Allison M. Kehlmann +26 more

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Nature Communications(2023)10.1038/s41467-023-41282-x

N/A

0DataRank · unranked

43 citations

David L. Drum, Ruochuan Sun, Yida Zhang, Feng Chen, Fengfei Sun +29 more

Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1022

N/A

0DataRank · unranked

55 citations

Laura M. Spring, Geoffrey Fell, Phoebe Ryan, Neelima Vidula, Arielle J. Medford +8 more

A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance

Breast Cancer Research(2024)10.1186/s13058-024-01859-w

N/A

0DataRank · unranked

4 citations

Christine E. Edmonds, Brian N. Dontchos, Gary Wang, Constance D. Lehman, Steven J. Isakoff +2 more

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.02.626446

N/A

0DataRank · unranked

5 citations

Win Thant, Elena Bitman, Ting Liu, Jie Liu, Eleftherios I. Paschalis +17 more

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2771

N/A

0DataRank · unranked

42 citations

Bogang Wu, Haley Barnes, Arielle J. Medford, Bryanna L. Norden, Annika Putur +16 more

Current landscape of sequencing ADCs in metastatic breast cancer

Therapeutic Advances in Medical Oncology(2025)10.1177/17588359251396656

N/A

0DataRank · unranked

4 citations

Lis V. Ravani, Beverly Moy, Arielle J. Medford, Steven J. Isakoff, Ting Liu +5 more